Natacyn
Payments companies reported to CMS as associated with Natacyn. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Natacyn, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Natacyn
These are the largest totals companies reported as associated with Natacyn. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Charles Shields | Knoxville, TN | Optometrist | $590.29 |
| Michael Ensor | Memphis, TN | Optometrist | $327.42 |
| Paul Taupeka | Mobile, AL | Neuro-Ophthalmology | $323.26 |
| Joshua Groetsch | Metairie, LA | Ophthalmology | $272.44 |
| Jeffrey Maher | Swansea, IL | Ophthalmology | $242.72 |
| Steven Lee | Saint Louis, MO | Ophthalmology | $242.72 |
| Joseph Gira | Des Peres, MO | Ophthalmology | $242.72 |
| Ryan Smith | Upland, CA | Ophthalmology | $191.28 |
| Anne Floyd | Glendale, AZ | Ophthalmology | $187.93 |
| Daniel Churgin | Phoenix, AZ | Ophthalmology | $173.06 |
Prescribed Natacyn?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.